Recon Strategy
Contact

Insights

Fifteen+ years of
Healthcare thinking.

Several hundred perspectives on the questions facing payers, providers, biopharma, medtech, and digital health — plus our running read on the clinical literature. Start with our sharpest work, or filter to your world.

Sector
All
NEJM opinion
The New England Journal of Medicine

An opinionated take on NEJM highlights for the first quarter of 2023

  • NEJM
Hypertension?! Antihypertensive drugs are so 80s and 90s (well, except…

Read more